Air pollution fine particles linked to poor sperm quality

Health News (Reuters) - Mon, 12/11/2017 - 23:54
(Reuters Health) - Exposure to fine particles in air pollution may be another factor that affects men’s sperm quality and their fertility, suggest researchers in Taiwan.
Categories: Health

Amgen's Kyprolis improves overall survival in blood cancer patients

Health News (Reuters) - Mon, 12/11/2017 - 23:36
(Reuters) - Amgen Inc said on Monday a final analysis of late-stage trial data showed that its Kyprolis combined with two other drugs helped blood cancer patients live longer.
Categories: Health

Retirement linked to longer, better sleep

Health News (Reuters) - Mon, 12/11/2017 - 22:57
(Reuters Health) – As work worries abate, sleep difficulties may also diminish when workers make the transition to retirement, according to a recent study from Finland.
Categories: Health

Promising responses seen with Agios leukemia drug in study

Health News (Reuters) - Mon, 12/11/2017 - 22:03
(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.
Categories: Health

Commuters often exposed to damaging noise levels

Health News (Reuters) - Mon, 12/11/2017 - 20:48
(Reuters Health) - Loud noise exceeding levels that can damage hearing is regularly encountered by commuters using buses, subways and even biking, a Canadian study suggests.
Categories: Health

Kids continue to die in window-blind accidents, despite safety warnings

Health News (Reuters) - Mon, 12/11/2017 - 20:43
(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.
Categories: Health

Medical lab trade group sues over U.S. reimbursement cuts

Health News (Reuters) - Mon, 12/11/2017 - 20:32
(Reuters) - A U.S. trade association representing medical laboratories filed a lawsuit on Monday challenging a new reimbursement system used by the federal government that it said would reduce how much Medicare pays for labs by about $670 million in 2018.
Categories: Health

FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog

Health News (Reuters) - Mon, 12/11/2017 - 20:05
(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog.
Categories: Health

'Ground-breaking' new drug gives hope in Huntington's disease

Health News (Reuters) - Mon, 12/11/2017 - 19:20
LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
Categories: Health

Austria to drop impending smoking ban, bucking Western trend

Health News (Reuters) - Mon, 12/11/2017 - 19:01
VIENNA (Reuters) - While much of the West has barred smoking in restaurants and bars, Austria's impending ban is set to be stubbed out.
Categories: Health

Opioid painkiller prescriptions may run in families

Health News (Reuters) - Mon, 12/11/2017 - 18:28
Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.
Categories: Health

Exclusive: Philippines defied experts' advice in pursuing dengue immunization program

Health News (Reuters) - Mon, 12/11/2017 - 17:48
MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.
Categories: Health

CanniMed asks Canadian regulators to intervene in hostile Aurora bid

Health News (Reuters) - Mon, 12/11/2017 - 17:35
(Reuters) - Medical marijuana company CanniMed Therapeutics Inc has asked Canadian regulators to intervene as it seeks to prevent a hostile takeover by bigger rival Aurora Cannabis Inc.
Categories: Health

'Ground-breaking' new drug gives hope on Huntingdon's disease

Health News (Reuters) - Mon, 12/11/2017 - 14:34
LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
Categories: Health

Roche: Tecentriq cocktail slows kidney cancer progression

Health News (Reuters) - Mon, 12/11/2017 - 12:25
ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin for the initial treatment of advanced kidney cancer reduced the risk of the disease worsening or of death in certain patients, the Swiss drugmaker said on Monday.
Categories: Health

Indonesia races to contain diphtheria outbreak ahead of 2018 Asian Games

Health News (Reuters) - Mon, 12/11/2017 - 11:45
JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capital’s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.
Categories: Health

GSK's new pharma head on lookout for cancer deals to boost pipeline

Health News (Reuters) - Mon, 12/11/2017 - 11:17
LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
Categories: Health

Merck raises stakes in lung cancer as rivals close in

Health News (Reuters) - Mon, 12/11/2017 - 07:24
LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.
Categories: Health

Novartis CAR-T therapy leads to durable response in lymphoma study

Health News (Reuters) - Mon, 12/11/2017 - 00:14
(Reuters) - Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy continued to respond at least six months after treatment, according to updated data released at a medical meeting on Sunday.
Categories: Health

Hospital operators in merger talks to form U.S. industry leader: WSJ

Health News (Reuters) - Sun, 12/10/2017 - 22:25
NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.
Categories: Health
Syndicate content

eXTReMe Tracker